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To study the cellular mechanisms of intcrleukin-I (IL-l) in the pituitary corticotroph, we studied the properties of IL-1 receptors on a mouse 
pituitary ACTH-producing cell line, AtT-20. Scatchard plot analysis revealed a single type of receptor with a Kd (dissociation constant) of 93 pM. 
and 482 binding sites/cell. [i’sl]lL-lo: binding competed with IL-la and IL-l/3 in an equimolar fashion. A 24 h pre-incubation with either CRH, 
epinephrine or nor-epincphrine increased the [‘*‘I]IL-la binding sites in the AtT-20 cells and conversely, a similar pre-incubation with either 
dexamethasone or tumour necrosis factor-a (TNFor) decreased them without affecting the affinity of the receptors in either case. 
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1. INTRODUCTION 
In recent years, it has been shown that lL-1, a cy- 
tokine originally isolated as a lymphocyte activating 
factor, has multiple biological activities, not only in 
regulating the immune system but also in modulating 
endocrine and metabolic functions [l-3]. In the hypo- 
thalamic-pituitary-adrenal (HPA) axis, it has been 
reported that IL-1 stimulates corticotropin-releasing 
hormone (CRH) synthesis [4] in and release [5,6] from 
the hypothalamus, ACTH synthesis [7] in and release 
[8,9] from the anterior pituitary, and glucocorticoid syn- 
thesis in the adrenal gland [lO,ll]. Although the cy- 
tokine is presumed to affect endocrine cells via a specific 
receptor on the plasma membrane as immune com- 
petent cells [12], information about the IL-1 receptor 
(IL-1R) on these neural or endocrine cells is quite 
limited. 
We and others have previously reported that recom- 
binant human IL-I binds specifically to AtT-20 cells, a 
mouse corticotrophic cell line, and stimulates the syn- 
thesis and reiease of ACTH and &xaclorphin through 
early activation of protein kinases [13-151. In the pres- 
ent study, we further characterized the labeled IL-la 
binding to AtT-20 cells and studied the effects of vari- 
ous cytokines, steroids, hypothalamic peptides and ca- 
techolamines on the IL-la binding to AtT-20 cells. 
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2. MATERIALS AND METHODS 
2. I. C,vrokl’nes arid ltorrnorics 
Human IL-la, human lL-1p (lymphocyte activating factor with an 
activity of 2 x IO’ half-maximum Ulmg protein) and human IL-2 (12 
x lob reference Ulmg protein) were synthesized by recombinant DNA 
technology [16.17]. Human IL-6 (I x IO” U/l93 fig protein) was a gift 
from Ajinomoto Corp. (Kawasaki, Japan). Human tumour necrosis 
factor-a (TNFa) was donated from Dninippon Pharmaceutical Co. 
(Osaka, Japan). Arginine-vasopressir (AVP) and human/rat corlico- 
tropin-releasing hormone (CRH) were purchased from Peninsula Lab- 
oratories Inc. (Belmont, CA) and dexamethasone and dopnmine were 
from Sigmn Chemical Co, (St. Louis, MO). Epincphrine and nor- 
epincphrine were obtained from Sankyo Corp. (Tokyo, Japan) and 
Daiichi Pharmaceutical Co. (Tokyo, Japan), respectively. 
A subclone of AtT-20/Dl6v cells provided by Dr 0. Midorikawa, 
Kyoto University, was used in this study. Cells were grown in 
Dulbccco’s Modified Eagle’s Medium (Nissui, Tokyo, Japan) supple- 
mented with 10% fetal calf serum at 37’C under a humidified alma- 
sphere of 5% COi:95% air. 
2.3. Pituitury cell culture 
Anterior pituitaries from male Wistar rats or male New Zealand 
White rabbits, or whole mouse pituitaries from male Balb/c57 mice 
were enzymatically dispersed with collagenase type I (Worthington 
Biochemical, Freehold, NJ) and DNase (Sigma) as previously dc- 
scribed [IS]. The cells were incubated for 4 or 5 days in the same 
medium as AtT-20 cells before the binding study. 
2.4. Rudioiodlnrrtion oJrrcombinrmt(r)il-la 
rlt-la was labeled with lz51 using the chloramine T method and 
purified by Scphadex GIOO (Pharmacia, Uppsala, Sweden) column 
chromatography. The specific aclivity of the iodinated rIL-la was 
approximately 300 yCi&g. 
2.5. Bhditrg assuy 
The binding study was performed as reported previously [I91 with 
slight modifications. Bricfiy, cells harvested gently with a rubber po- 
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liceman were washed twice with cold binding medium (RPM1 1640 
containing 0.3% bovine serum albumin and 10 mM IIEPES) and the 
viability of the cells was secured by the Trypan blueexclusion test. The 
same number of cells, approximately I-S x I Oh, was prepared in micro- 
centrifuge tubes and the binding study was started by incubating the 
cells with [1251]lL-la at 4% for S h. After the binding incubation, 
unbound radioactivity was separated from the cells by centrifuging the 
incubation mixture for 2 min at 1,000 x g and discarding the super- 
nutuni. Radioactivity remaining in the cell pellet was measured by a 
gamma counter, Non-specific binding was determined in the presence 
of a 2004old excess of unlabeled IL-I. 
2.6. Dara analysis 
Kd and number of binding sites were calculated according to the 
method of Scatchard [20]. Values shown are mean t S.E. For compar- 
ison between means, data were analysed by the two-tai!ed Student’s 
I test. 
3. RESULTS 
To assess ‘the specificity of the binding, IL-lcz, IL-l& 
IL-2, IL-6, TNF, CRH, AVP, dexamethasone, do- 
pamine, epinephrine or nor-epinephrine was incubated 
with [“51]IL-lct. As shown in Fig. 1, only IL-la and 
IL-l/3 competed in an equimolar fashion with the 
[1”51]IL-la binding. The other materials tested had no 
effect on [1251]IL-la binding to AtT-20 cells. 
Scatchard plot analysis of the binding data yielded an 
apparent Kd of approximately 9.3 x 10-l’ M with ap 
proximately 482 binding sites/cell. Only one component 
of binding site was detected, as shown in Fig. 2. 
Effects of hypothalamic peptides, catecholamines, 
dexamethasone and cytokines on the IL-la binding to 
AtT-20 were next examined and the data are illustrated 
in Fig. 3, and Table 1. When AtT-20 cells were in- 
cubated for 24 h with various concentrations of CRH 
immediately before the binding experiment, a con- 
centration-dependent increase in the IL-la binding was 
observed, as shown in Fig. 3. Incubation for the same 
period with dexamethasone or TNFa decreased the IL 
1 binding significantly. The same period of pre-incuba- 
tion with either IL-2, IL-6, AVP or dopamine did not 
affect IL-la binding to AtT-20 cells (data not shown). 
Although epinephrine and nor-epinephrine did not 
affect IL-la binding under similar pre-incubation con- 
ditions, partial effects were observed when the pre-in- 
cubation media were repeatedly supplemented with 
fresh epinephrine or nor-epinephrine at 0,2,4,6, IO and 
21 h during the 24 h pre-incubation period. 
Kinetic studies revealed that significant modification 
of the IL-la binding site by all substances tested were 
not apparent after a 24 h incubation (data not shown). 
Changes in the IL-let binding were characterized by 
Scatchard plot analysis. As shown in Table I, IL-la 
binding sites in AtT-20 cells were increased by CRH, 
epinephrine and nor-epincphrine and decreased by 
dexamethasone and TNF#. &s were not significantly 
affected by any treatment. 
As shown in Table II, pituitary cells obtained from 
several species of animals also demonstrated low 
numbers of specific IL-la binding sites. 
4. DlSCUSSION 
The results reported here show that the binding of 
[l~SI]IL-la to AtT-20 cells satisfies the criteria for a 
receptor; it is rapid, stable, saturable, of high affinity, 
low capacity and high specificity. [‘z51]IL-la appeared 
to bind to a single class of binding sites as demonstrated 
by the linearity of Scatchard plot, as reported previ- 
ously [21,22]. It has been reported that a variety of ceil 
types express IL-1R which can be divided into at least 
two classes of receptors, a large molecular weight type, 
~80, and a small type, ~68 [23-2S]. IL-1R found in 
T-cells, fibroblasts and many other cell types, binds 
TNF. Dexamelhasone. Nor- spinephtine. EpinwhrIno 
lL2. IL& rat/humanCRH, AVP , DOPamlne 
peptido6 (Ml 
I 4 
lo-” lo-‘0 10-s 10-a 
Fig. 1. Effect of unlabeled IL-1 and other materials on binding of [‘2’I]IL-la to AtT-20 cells. Cells (IO’celWtube) were incubated with l’BIJL-lc 
(23 pM) with unlabeled IL-1 and other materials at the indicated concentrations. 
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Ial - IL1 4 added (cpm X lo- 4, 
1 2 3 4 5 6 I 
‘=5( - IL1 Q bound kpm X 10-3) 
FIN 2 Spedic bmdmg OC [“‘t]IL-la IO AtT-20 cells and Scatchard 
ploi dnalysls AIT-20 cells (IO* cells/tube) were Incubated with various 
drlutlons of [“‘IJIL-la for 5 h at 4% The d&a IS reprcsenrauve of 5 
cxpcnments 
IL-la and IL-l/? indlstinguishably. whereas the small 
molecular type receptor, expressed on B-cells and mac- 
rophages. dlscrimmates between them. As shown m Fig 
I. IL-la and IL-IS are equallycompetttlve with [“51]IL- 
la and the dissociation constant of 9.33 x IO-” M IS 
similar to the reported Kd of the T-cell type IL-1 re- 
ceptor [26]. These data suggest that AtT-20 ce!ls exam- 
med m our expenments possibly express T-cell type 
IL-IR and are compatible with a recent report which 
indicated a partial sequence of the AtT-20 IL-1 receptor 
molecule [29]. 
Hormonogenesls m the corticotroph 1s controlled 
mainly tiy CRH, vasopressin and glucocortlcold 
hormones, but is also afl ected by many other hormones. 
AtT-20 cells maintain consrderable responses to these 
factor. Among these factors, CRH. AVP, IL-I, iL-2. 
IL-6, TNFcc, epinephnne. nor-epmephnne and do- 
pamme are stimulatory [13,30] and dexamethasone IS 
mhlbitory [3 I] to AtT-20 cells. In this study, we showed 
that IO nM of CRH, 1 ,uM of epinephrme and I PM of 
nor-epmephrinc Increased the number of IL-1R on 
AtT-20 celIs. whereas IO .uM of dexamethasone and 10 
February 1992 
De=0 10 9 IO a IO ’ IO t 10 %A) 
TIN CRIlO 10 ‘2 IO ” rir ‘0 10 t IJ ‘f&II 
EM 0 IO ” 10 0 IO ’ IO %.v 
FIN 3 Dosc-depcndent lkt of deramcthasone (Dex) TNF. CRH. 
epmephrme (E) and nor-cpmuphnne (NE) on IL-IaR expressIon 
AIT- cells were prc-Incubated for 24 h with or without Increasing 
concentrations of mdlcatcd mafenals At the end of the mcubanon the 
prc-Incubated cells (5 x IO’ eells/~ube) were Incubated with [“51]IL-la 
( 100 pM) for 5 h Each point represents the mean of duphcatc dcter- 
minatlons 
nM of TNFa decreased It without apparent changes of 
their dissociation constants, suggcstmg that these 
changes are due to IL-IR inductron and reduction on 
the AtT-20 cells. Although It 1s known that TNFa is 
cytotoxic for some tumour cells in culture [32], we used 
the same number of cells m TNFa-treated and non- 
treated vials after confirmmg cell vlablhty and are con- 
fident that the changes are due to cytotoxlc effect even 
m the TNFa-related experiments. 
As all the changes In IL- I R bmdmg observed In thus 
study required at least 24 h of mcubatlon. the effects 
may require a gene expresslon and subsequent protem 
synthesis related to IL-IR. as platelet-denved growth 
factor (PDGF) induces IL-1R in Balb/3T3 cells [33]. 
The cell prohferation cycle of the AtT-20 cells was also 
Table I 
Rrgulatlon of the IL-IaR on AtT-IO cells 
slteskcll & (IO ” M) 
Conlrul 482 + 27 93+17 
CRH (IO ’ M) 711 f 87* 144238 
Cpmephnne (IO’ M) 158 t 99. 166 +04 
Nor-epmephnnc ( lOa M) 603 z 61’ llSr07 
Dexamethasonc (IO 5 M) 334 + 24’ lr6i30 
TNF(l0” M) 347 + 25. I_ '-3 + 23 
- 
In each rcnchng lube. 5 x IO”cells rreared with rhe rndlcarcd marerlals. 
were Incubated with [‘z’?jlL-lz (100 pM) tar 5 h l PcOOS !m = 3) 
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Table II 
IL-la bmdmg to normal pmutary cells 
[“‘I]IL-la Unlabeled Counts 
IL-la (cpm) 
Rat anterior pnuttary cells + 132 
+ + 54 
Mouse whole pttuttary cells + 739 
+ + 85 
Rabbtt antenor pttunary cells + 721 
+ + 63 
Total 193222 
- 
Normal pnunary cells (I 25 x IO’ cells/tube) were mcubatcd with 
[“‘l]lL-la (100 PM) Non-spectfic binding was detcrmmcd wnh IO- 
fold molar excess of unlabclcd IL-la 
possibly modilied by these vartous ageuto and might 
contribute to the changes in these experiments. Al- 
though several reports have been published concerning 
the modulation of IL-1R expressicn [34--371, detalled 
mechanisms resulting in these changes, Including ours, 
remain to be c:ucidated. 
A variety of interacttons among heterogenous re- 
ceptor systems in the endocrine, immune and nervous 
systems have been reported. In the field of cytokine- 
neuroendocrine interactions. only a few reports con- 
cerning these interactions have been published, i e. IL-I 
Increased vasopressm effect on ACTH release from 
AtT- 20 cells [38], IL-1 preserved catecholamine ffects 
on ACTH release from rat pituitary monolayer cells 
[39], and glucocorticotd induced IL-1R on human pe- 
ripheral l+‘ood lymphocytes [37]. Our data shown here 
not only confirm the previous observattons about CRH 
[40] but also extend the number of substances which 
modtfy IL-IR on the corticotrophic cell line and suggest 
the existence of the bi-directional interactions between 
cytokiues and hormones on the surface of an endocrtne 
cell. 
It IS stall controverstal whether IL-1 dtrectly affects 
ACTH release from normal pituitary cells [8.9] We 
found low numbers of considerably specific IL-1 bm+ 
ing sites in normal rat, mouse and rabbit pituitary cells 
m this study. Although tt IS hard to assess the 
physiologtcal significance of our study concerning AtT- 
20 cells. and the specific binding in these normal pi- 
tuitaries were too small to be further characterized, this 
informatton, co.nbined with the results usmg AtT-20 
cells, favours the notion that human IL-la acts directly 
on the pituitary cells. 
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